Sweden · Medical and donor conditions

A clinical laboratory office with a microscope, specimen containers and a closed review binder

Sweden: Medical and Donor Requirements in Surrogacy-Related Treatment

Short answer: clinical rules do not create a surrogacy pathway

If the question is whether Sweden has a set of medical and donor criteria that makes a surrogacy program available domestically, the central answer is no. Swedish law regulates assisted reproduction and donation of eggs, sperm and embryos, but those rules do not create a route for a surrogacy arrangement to be carried out in Swedish healthcare. Government legislative material has described surrogacy as not expressly prohibited by a standalone statutory ban while stating that it is not permitted within Swedish healthcare; a 2025 government inquiry repeats the healthcare position. These statements must be read together. The absence of a standalone ban is not permission for a Swedish clinic to perform the procedure, and it does not resolve every question about private conduct, contracts or legal parentage. The medical and donor rules below concern regulated assisted reproduction. They are a comparison framework, not an eligibility checklist that authorizes surrogacy.

Which rules are law, and which are clinical policy?

The main binding framework includes the Genetic Integrity Act (2006:351), especially chapters 6 and 7; the National Board of Health and Welfare’s consolidated regulations SOSFS 2009:32 on use of tissues and cells in healthcare; SOSFS 2009:30 on donation and procurement; and the Quality and Safety Act (2008:286). The precise rule depends on the treatment: insemination, IVF with the recipient’s own gametes, IVF using donated gametes, or transfer of a donated embryo are not interchangeable. Binding legislation and regulations set legal conditions and prohibitions. Official guidance explains how the authority reads or administers those rules. A clinic’s age limits, funding criteria, document checklist or additional risk controls may be operational policy unless a specific legal provision makes them mandatory. Ask the clinic to identify the legal basis for each requirement instead of assuming every clinic rule is a statute.

Assessment of the person receiving treatment

For regulated treatment using donated sperm, eggs or embryos, the provider must make a special assessment of whether treatment is appropriate in light of the prospective parent or parents’ medical, psychological and social circumstances. A physician participates together with a professional with relevant behavioural-science competence. Treatment may proceed only if it can be assumed that the future child will grow up in good conditions. The official guidance recommends considering the person’s ability to function as a parent throughout the child’s upbringing, age, health and disabilities, living circumstances, the couple’s relationship or a single person’s support network, and the person’s attitude to telling the child about their biological origins. For donated embryos, the assessment should also consider the ability to handle the child’s genetic connection to another family and possible future contact. The reviewed national provisions do not establish one universal statutory maximum age for every recipient; this does not prevent a clinic or public-funding scheme from applying separate criteria.

Medical screening and pregnancy safety

The clinical rules also require attention to the recipient’s health and to the safety of pregnancy. Before treatment, an assessment must consider whether the person has the medical capacity to become pregnant through the proposed method. The current consolidated regulations require recipient testing for markers of HIV-1 and HIV-2, hepatitis B, hepatitis C and syphilis. HTLV-I/II testing is required in specified higher-prevalence circumstances, including certain geographic or partner/family links. Depending on the person’s history, additional tests may be needed, for example for malaria, tuberculosis, CMV, toxoplasmosis, EBV, Trypanosoma cruzi or leishmaniasis. These examples are not a universal test panel for every person. The provider must also assess whether pregnancy would be appropriate for the woman’s or child’s safety. Assisted reproduction must not be performed where pregnancy, or another infection or disease, could endanger the life or health of the woman or child. These are rules for regulated assisted reproduction, not a bespoke surrogacy protocol.

Who may donate, and when can consent be withdrawn?

A gamete donor must be an adult and give written consent to the specific use of the gametes. For eggs or sperm used in IVF, the donor may withdraw consent until fertilisation; for sperm donated for insemination, the donor may withdraw consent until insemination. For transfer of a donated embryo, the woman treated first and, where applicable, her spouse or cohabiting partner may withdraw their written consent until the embryo is transferred. The provider must explain these time limits before treatment. Sperm from a deceased donor may not be used for insemination; neither sperm nor eggs from a deceased donor may be used for fertilisation. Official general advice separately addresses embryos that had already been fertilised and remain frozen after a donor’s death: the provider should primarily consider the future child’s right to seek contact with the donor and may assess, case by case, whether there are grounds to proceed using those embryos. This is case-specific guidance, not a blanket authorization. The physician selects a suitable donor for treatment involving donated gametes or an embryo. These are statutory requirements for the covered treatment pathways. They do not mean that a person can nominate a donor and require a clinic to accept that donor, and they do not make an intended-parent or surrogate arrangement permissible. Donor consent is a treatment-specific legal consent, not a substitute for separate analysis of any surrogacy agreement.

Donor assessment, tests and suitability

Donor selection is not based on a name or a short profile alone. The donor’s identity must be verified, and information must be obtained about general health, relevant medical history, events and behaviours that may affect transmission risk. For an allogeneic donation, the regulations require a health declaration and a supplementary interview. The declaration can cover sexual behaviour, travel, geographic origin, extended stays abroad, injection-drug use, accidents, vaccinations, medication and medical or non-medical procedures. The interview must respect the donor’s privacy. The history and interview inform the laboratory tests and other checks required by the applicable rules, including Annex 4 to SOSFS 2009:30 for gamete donors. If necessary to identify risk, the provider may also need relevant medical-record information, discussion with treating clinicians or a physical examination. A positive screening result or another risk may make a donor unsuitable; the exact decision depends on the applicable safety rules and the documented individual assessment.

Where treatment may lawfully be performed

Treatment involving donated gametes or embryos is subject to facility and authorization rules. Under chapter 7, section 4 of the Genetic Integrity Act, IVF using donated eggs or sperm may be performed only at the hospitals specified by law, with units for medical-degree training and research; another provider must have the required permit from the Health and Social Care Inspectorate (IVO). The statutory and regulatory scheme also distinguishes publicly funded hospitals, private healthcare providers with IVO authorization and tissue establishments that need their own authorization for handling and traceability of human cells. Do not rely only on a clinic’s website, an agency referral or a statement that a clinic is “licensed.” Confirm the exact legal entity, the activity covered by its permit and whether it may perform the specific procedure and handle the relevant gametes or embryos.

The narrow statutory route for embryo donation

Swedish law permits a narrow form of transfer of a donated fertilised egg to another woman, but it is not a surrogacy route. Under chapter 7, section 3a of the Genetic Integrity Act, an embryo created for transfer to one woman may be transferred to another woman only if the woman first treated, and her spouse or cohabiting partner where applicable, have given written consent; the first-treated woman and, where applicable, her partner are already parents of at least one child; and the embryo was created using the first-treated woman’s own egg or, if she has a spouse or cohabiting partner, sperm from that partner. The woman treated first and, where applicable, her spouse or cohabiting partner may withdraw that consent until the embryo is transferred. These conditions are specific and cumulative. The provision concerns donation of an embryo under the statutory treatment framework; it does not authorize a clinic to create or transfer an embryo for the purpose of a surrogacy arrangement, nor does it decide who will be the child’s legal parent in a surrogacy case.

Donor identity, family limits and embryo-transfer rules

Donor safeguards continue after the treatment decision. The provider must record donor information in a special medical record that is kept for at least 70 years. A child conceived through the covered donor treatment has a right, once sufficiently mature, to access the donor information recorded in that journal. After reaching sufficient maturity, a person conceived through the covered treatment may also request in writing that their own information be added to the special journal and may access information in that journal about other people conceived using gametes from the same donor. The donor must be informed that the child may contact them in the future and that the donor may need to be contacted for later testing or investigation. This means that donor conception under the Swedish framework is not anonymous in the sense of guaranteeing that the donor’s identity will never be disclosed to the child. A separate tissue-establishment traceability register serves a different safety purpose; do not confuse that register with the special medical journal. The regulations also limit a sperm or egg donor to children in six families in Sweden, unless exceptional reasons justify allowing an additional family to have a child using the same donor; more specifically, a couple or a single woman may donate embryos for a child to be born in one additional family beyond their own; a gamete donor who has already reached six families may also participate in embryo donation for one additional family. In double donation, where both egg and sperm are donated, children may result in no more than one family. In one menstrual cycle, a woman may not be inseminated with sperm from more than one donor; embryos derived from eggs from more than one woman may not be transferred into another woman in the same procedure. As a general rule, one embryo is transferred in an IVF cycle; two may be transferred only where the risk of a twin pregnancy is assessed as low. The recipient(s) must be informed about twin-pregnancy risks and offered a discussion with a paediatrician.

Practical checklist before relying on a clinic or donor

Before relying on any proposed treatment, take these steps.

  1. Describe the intended procedure in writing: who provides the egg and sperm, who carries the pregnancy, and whether the plan is insemination, IVF, embryo donation or surrogacy.
  2. Ask the Swedish provider to identify the exact statutory provision that permits that procedure; a general statement that egg or embryo donation is legal is not enough.
  3. Verify the provider’s IVO authorization for the specific activity and, where relevant, the tissue establishment’s authorization and traceability arrangements.
  4. Request the current written medical criteria, donor-screening protocol, required tests and consent forms. Ask which requirements come from legislation, which from Socialstyrelsen regulations, and which are clinic or regional-funding policy.
  5. Confirm how donor identity is recorded, how the child can later obtain information, how long records are kept, and when consent can be withdrawn.
  6. Ask how pregnancy risks are assessed and what happens if a screening result is abnormal.
  7. If a covered donor-assisted insemination or IVF treatment is refused under the special suitability assessment in chapter 6, section 3, or chapter 7, section 5, of the Genetic Integrity Act, the applicant may ask the National Board of Health and Welfare (Socialstyrelsen) to review the refusal. A decision by Socialstyrelsen under those provisions may be appealed to a general administrative court; leave to appeal is required for a further appeal to the Administrative Court of Appeal. This review route is tied to the statutory suitability assessment, not a general appeal route for every clinic refusal, and it does not compel a clinic to provide surrogacy, which is not a permitted treatment pathway in Swedish healthcare. For a program abroad, separately check the destination country’s law and medical rules, and obtain advice on parentage, recognition, nationality and travel before proceeding. Those issues are not answered by Swedish donor-screening rules. The official consolidated pages consulted identify amendments through HSLF-FS 2024:19 for SOSFS 2009:32 and HSLF-FS 2024:18 for SOSFS 2009:30. Keep the provider’s written answer and the cited legal provision with your records; a marketing description alone is not evidence of legal authority.

Sources and legal status

Official Swedish sources. The government inquiry and legislative materials describe policy and interpretation; they are not substitutes for binding statutory text.

  1. Genetic Integrity Act (2006:351), chapters 6–7
  2. Socialstyrelsen regulation SOSFS 2009:32, use of tissues and cells
  3. Socialstyrelsen regulation SOSFS 2009:30, donation and procurement
  4. Quality and Safety Act (2008:286), human tissues and cells
  5. Prop. 2017/18:155, Modernare regler om assisterad befruktning och föräldraskap
  6. Official government inquiry SOU 2025:119, surrogacy discussion

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards